Hamartin and Tuberin Expression in Human Tissues

[1]  L. Liau,et al.  Hamartin expression and interaction with tuberin in tumor cell lines and primary cultures , 2001, Journal of neuroscience research.

[2]  M. Rosner,et al.  The TSC1 gene product, hamartin, negatively regulates cell proliferation. , 2000, Human molecular genetics.

[3]  P. Crino Tuberous sclerosis complex: Developmental perspectives in psychiatry , 2000 .

[4]  H. Vinters,et al.  The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho , 2000, Nature Cell Biology.

[5]  L. A. Haddad,et al.  Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney. , 2000, American journal of physiology. Renal physiology.

[6]  F. Tibayan,et al.  Adenocarcinoma of the rectum with associated colorectal adenomatous polyps in tuberous sclerosis: a case report. , 2000, Journal of pediatric surgery.

[7]  A. V. D. van den Ouweland,et al.  Characterization of the Cytosolic Tuberin-Hamartin Complex , 1999, The Journal of Biological Chemistry.

[8]  S. Ng,et al.  Lymphangiectasia within angiomyolipoma in a tuberous sclerosis patient. , 1999, Clinical imaging.

[9]  P. Mischel,et al.  Cortical Dysplasia, Genetic Abnormalities and Neurocutaneous Syndromes , 1999, Developmental Neuroscience.

[10]  E. Henske,et al.  The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[11]  T. Tsuji,et al.  Tuberous sclerosis associated with multiple hepatic lipomatous tumors and hemorrhagic renal angiomyolipoma. , 1999, Internal medicine.

[12]  Y. Konishi,et al.  Distribution of Tsc2 protein in various normal rat tissues and renal tumours of Tsc2 mutant (Eker) rat detected by immunohistochemistry , 1999, Virchows Archiv.

[13]  H. Vinters,et al.  Co‐Localization of TSC1 and TSC2 Gene Products in Tubers of Patients with Tuberous Sclerosis , 1999, Brain pathology.

[14]  R. Yeung,et al.  Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Scheithauer,et al.  Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex , 1998, Cancer.

[16]  R. Snell,et al.  Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. , 1998, Human molecular genetics.

[17]  M. Mizuguchi,et al.  Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis , 1997, Acta Neuropathologica.

[18]  S Povey,et al.  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. , 1997, Science.

[19]  E. Golemis,et al.  The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis* , 1997, The Journal of Biological Chemistry.

[20]  P. Mischel,et al.  Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[21]  J. Declue,et al.  Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY (*) , 1995, The Journal of Biological Chemistry.

[22]  N. Migone,et al.  9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. , 1994, Human molecular genetics.

[23]  M. Fujishima,et al.  Gastrointestinal involvement in tuberous sclerosis. Two case reports. , 1994, Journal of clinical gastroenterology.

[24]  A. Green,et al.  Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients , 1994, Nature Genetics.

[25]  S. Thomas,et al.  Identification and characterization of the tuberous sclerosis gene on chromosome 16 , 1993, Cell.

[26]  A. Bretscher,et al.  Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. , 1993, Journal of cell science.

[27]  P. Huttenlocher,et al.  Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association , 1992 .

[28]  MANUEL R. GOMEZ,et al.  Phenotypes of the Tuberous Sclerosis Complex with a Revision of Diagnostic Criteria , 1991, Annals of the New York Academy of Sciences.

[29]  R. Siegel,et al.  Combined median and ulnar nerve lesions complicating fractures of the distal radius and ulna. Two case reports. , 1968 .

[30]  B. Portmann,et al.  Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. , 1999, The American journal of surgical pathology.

[31]  J. de Gunzburg,et al.  Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. , 1997, The American journal of pathology.